Protagonist Therapeutics (PTGX)

• Market cap: $4.79B
• 1 day: 0.58%
• 5 days: -0.35%
• 1 month: 19.96%
• 3 months: 42.75%
• 6 months: 73.76%
• Year to date: 97.38%
• 1 year: 67.63%
• 5 years: 233.8%
• 10 years: 557.61%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Employees: 130